Companies: 10,795·Total market cap: $144.5T
Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXXNASDAQHealthcare● Active
$0.65
+$0.01(+1.51%)
Market Cap$13219377
P/E Ratio—
52W High$1.55
52W Low$0.46
ForecastMarket CapPE Ratio

Lexaria Bioscience Corp.（LEXX）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

lexx · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 100.0%

12 个月目标价

High

$1.50

Consensus

$1.50

+132.0% upside

Low

$1.50

Median: $1.5 · Last Close: $0.65

Lexaria Bioscience Corp.（LEXX）的分析师共识为 Buy，基于过去 3 个月内 2 位华尔街分析师的评级。LEXX 的 12 个月平均目标价为 $1.50，相对当前价 $0.65 代表 +132.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.66↑ 1.76%

1-day model range: $0.65–$0.67. Peak: $0.67 (+1.76%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-15.8%
2028$1-22.4%
2029$0-25.5%
2030$0-26.9%
2031—-27.7%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%
6Buy
1Neutral
7Sell
RSI (14)66.7Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · LEXX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.63BUY
MA 10$0.63BUY
MA 20$0.61BUY
MA 50$0.77SELL
MA 100$0.74SELL
MA 200$0.86SELL
Current $LEXX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.63BUY
EMA 10$0.63BUY
EMA 20$0.64BUY
EMA 50$0.70SELL
EMA 100$0.75SELL
EMA 200$0.88SELL
Current $LEXX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2025-12-26
Maintains
Buy→Buy
HC Wainwright & Co.2025-07-29
Maintains
Buy→Buy
HC Wainwright & Co.2025-07-01
Maintains
Buy→Buy
HC Wainwright & Co.2025-01-24
Maintains
Buy→Buy
HC Wainwright & Co.2024-12-02
Maintains
Buy→Buy
HC Wainwright & Co.2024-11-25
Maintains
Buy→Buy
HC Wainwright & Co.2024-07-18
Maintains
Buy→Buy
Maxim Group2024-03-05
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on Lexaria Bioscience Corp. (LEXX) stock. Of the recent 8 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover LEXX.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

LEXX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$1M

↓ 52.3% YoY

Revenue Next Year

$0M

↓ 70.1% YoY

EPS This Year

$-0.68

EPS Next Year

$-0.26

↓ 61.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LEXX EPS of $-0.68 for the current fiscal year, based on estimates from 2 analysts. The LEXX revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

LEXX 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LEXX 的共识目标价为 $1.50（+132.0% 上行空间），分析师共识为 Buy。

LEXX 的短期预测（明日）为 $0.66（+1.76%）。 LEXX 对 2027 年的股价预测均值为 $1。 LEXX 对 2030 年的预测区间为 $0–$1。

Lexaria Bioscience Corp. 在 NASDAQ 上市，代码 LEXX。LEXX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

LEXX 预测 · 8 个问题

根据 2 位华尔街分析师，LEXX 的 12 个月平均目标价为 $1.50，最高 $1.50、最低 $1.50。若有图表，中位目标价可在上方查看。相对当前价 $0.65，隐含约 +132.0% 的上行空间。

LEXX 目标价LEXX 分析师目标价LEXX 12个月目标价目标价 LEXX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.